News 06 Mar 2024 Aktiia secures CHF 27 million to combat global hypertension crisis Aktiia, a pioneering Neuchâtel-based start-up specializing in cuffless blood pressure monitoring, has announced a significant financial milestone...
Industry Report 07 Nov 2023 Opportunities in the U.S. Medtech market This report explores the vital Swiss-U.S. medtech trade relations, highlighting the U.S. as a key market and detailing the dynamic factors shapin...
Rapport sectoriel 07 Nov 2023 Opportunités sur le marché américain des medtech Ce rapport explore les relations commerciales entre la Suisse et les États-Unis qui sont vitales dans le domaine des technologies médicales. Il m...
ニュース 28 Feb 2022 AIスキルの強化で組織力アップへ AI Master Class を提供中 AI、データ、自動化スキル、経営幹部スキルを発展させたい方は、ぜひAI Master Class オンラインプログラムをご活用ください。
News 14 Ago 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 23 Ago 2023 Sion’s Pôle Santé takes shape with the laying of the first stone Valued at CHF 86 million, the Pôle Santé campus aims to be a platform for the exchange of knowledge, experience and opportunities in the healthca...
Rapporti settoriali 07 Nov 2023 Opportunità sul mercato medtech statunitense Questo rapporto analizza le relazioni commerciali tra Svizzera e Stati Uniti, vitali nel settore delle tecnologie mediche, evidenziando l’importa...
Spotlight 15 Giu 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
Novità 02 Giu 2023 Le ultime ricerche indicano che il 20% delle aziende biotecnologiche europee ha attualmente sede in Svizzera Press release Una nuova ricerca condotta da IQVIA e pubblicata recentemente nello Swiss Biotech Report 2023 mostra che il 20% delle aziende biotecnologiche eur...
Research and Development 11 Lug 2023 Benefit from R&D Switzerland’s pragmatic collaboration between science and industry can help your company expedite the journey of your products to market. Learn h...
News 13 Feb 2023 Hôpital de La Tour will invest CHF 750 million to create a health campus in Geneva Leading private healthcare facility Hôpital de la Tour has entered into a CHF 750 million agreement to create a major health campus project to pr...
News 26 Mag 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 15 Nov 2022 Comet, Neuria and PMF-System win the Fribourg Innovation Award The canton of Fribourg has distinguished its most innovative companies. The Business Award went to Comet, the Start-up Award went to Neuria, and ...
Personalized health Empower your health-tech startup with AI and data knowhow: Complete our AI Masterclass The “AI opportunities for health-tech startups“ program is specifically designed for startups in the areas of healthcare and life sciences. It of...
News 03 Mag 2022 Why Switzerland’s pioneering role in blockchain combined with its biotech heritage makes it a source of innovation With the rise of new technologies such as blockchain and AI, the pragmatic regulatory approach of the Swiss authorities has become an important a...
News 31 Mag 2022 RetinAI enters a multi-year software license agreement with Novartis Building on their existing relationship, Bern-based RetinAI and pharma giant Novartis have entered a long-term collaboration with a multi-year so...